Strive, Inc. (United States) (ASST)
30.03
-0.08
(-0.27%)
USD |
NASDAQ |
Oct 02, 16:00
30.17
+0.14
(+0.47%)
After-Hours: 20:00
Strive Enterprise Value : 2.978B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.978B |
| October 01, 2026 | 2.985B |
| September 30, 2026 | 2.927B |
| September 29, 2026 | 2.919B |
| September 28, 2026 | 2.894B |
| September 25, 2026 | 2.930B |
| September 24, 2026 | 2.971B |
| September 23, 2026 | 2.893B |
| September 22, 2026 | 2.922B |
| September 21, 2026 | 3.003B |
| September 18, 2026 | 2.983B |
| September 17, 2026 | 2.835B |
| September 16, 2026 | 2.763B |
| September 15, 2026 | 2.777B |
| September 14, 2026 | 2.896B |
| September 11, 2026 | 2.781B |
| September 10, 2026 | 2.722B |
| September 09, 2026 | 2.704B |
| September 08, 2026 | 2.743B |
| September 04, 2026 | 2.741B |
| September 03, 2026 | 2.715B |
| September 02, 2026 | 2.510B |
| September 01, 2026 | 2.484B |
| August 31, 2026 | 2.502B |
| August 28, 2026 | 2.299B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.412B |
| August 26, 2026 | 2.279B |
| August 25, 2026 | 2.270B |
| August 24, 2026 | 2.134B |
| August 21, 2026 | 2.010B |
| August 20, 2026 | 1.839B |
| August 19, 2026 | 1.724B |
| August 18, 2026 | 1.566B |
| August 17, 2026 | 1.599B |
| August 14, 2026 | 1.527B |
| August 13, 2026 | 1.548B |
| August 12, 2026 | 1.533B |
| August 11, 2026 | 1.552B |
| August 10, 2026 | 1.537B |
| August 07, 2026 | 1.540B |
| August 06, 2026 | 1.526B |
| August 05, 2026 | 1.538B |
| August 04, 2026 | 1.535B |
| August 03, 2026 | 1.484B |
| July 31, 2026 | 1.428B |
| July 30, 2026 | 1.496B |
| July 29, 2026 | 1.424B |
| July 28, 2026 | 1.499B |
| July 27, 2026 | 1.516B |
| July 24, 2026 | 1.459B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Daxor Corp. | -- |
| Meridian Holdings, Inc. (California) | 4.569M |
| Hyperliquid Strategies, Inc. | 2.247B |
| TransMedics Group, Inc. | 3.158B |
| Abbott Laboratories | 196.37B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -257.60M |
| Revenue (Quarterly) | 0.14M |
| Total Expenses (Quarterly) | 257.74M |
| EPS Diluted (Quarterly) | -3.770 |
| Gross Profit Margin (Quarterly) | -1.02K% |
| Profit Margin (Quarterly) | -184.0K% |
| Earnings Yield | -63.60% |
| Normalized Earnings Yield | -51.70 |